Flagship Ventures 2007 General Partner Llc - Net Worth and Insider Trading

Over the past 18 months, Flagship Ventures 2007 General Partner Llc made no insider transaction in TransMedics Group Inc (TMDX). Other recent insider transactions involving TransMedics Group Inc (TMDX) include a net sale of 171,317 shares made by Tamer I Khayal , a net sale of 178,500 shares made by Waleed H Hassanein , and a net sale of 91,903 shares made by Stephen Gordon .

In summary, during the past 3 months, insiders sold 132,427 shares of TransMedics Group Inc (TMDX) in total and bought 0 shares, with a net sale of 132,427 shares. During the past 18 months, 573,408 shares of TransMedics Group Inc (TMDX) were sold and 2,500 shares were bought by its insiders, resulting in a net sale of 570,908 shares.

TransMedics Group Inc (TMDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures 2007 General Partner Llc made no insider transaction in Axcella Health Inc (AXLA). Other recent insider transactions involving Axcella Health Inc (AXLA) include a net sale of 5,221 shares made by Paul Fehlner ,

In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 209 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209 shares.

Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures 2007 General Partner Llc made no insider transaction in Sesen Bio Inc (SESN). Other recent insider transactions involving Sesen Bio Inc (SESN) include a net sale of 541,214 shares made by Thomas R Cannell , a net sale of 407,711 shares made by Monica Forbes , and a net sale of 259,049 shares made by Mark Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 71,436 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 71,436 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures 2007 General Partner Llc made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,223,316 shares made by Timothy A Springer , a net sale of 48,524 shares made by Carsten Brunn , and a net sale of 12,349 shares made by Peter G Traber .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 40,777 shares, with a net purchase of 40,777 shares. During the past 18 months, 2,681 shares of Cartesian Therapeutics Inc (RNAC) were sold and 40,777 shares were bought by its insiders, resulting in a net purchase of 38,096 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures 2007 General Partner Llc made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 21,126 shares made by David S. Ege , a net sale of 20,101 shares made by Eric D. Shaff , and a net sale of 8,632 shares made by Moltke Lisa Von .

In summary, during the past 3 months, insiders sold 36,381 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 36,381 shares. During the past 18 months, 83,200 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 83,200 shares.

Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of BG Medicine Inc (BGMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BG Medicine Inc (BGMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BG Medicine Inc (BGMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Flagship Ventures 2007 General Partner Llc made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 205,692 shares made by David P Schenkein , a net sale of 8,791 shares made by Washburn Theodore James Jr. , and a net sale of 14,160 shares made by James William Burns .

In summary, during the past 3 months, insiders sold 93,495 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 93,495 shares. During the past 18 months, 358,881 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 358,881 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.